Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
Oct 16, 2019
| Rachel Schwartz
AAM Reaction to FDA Statement on Patient Access to Generic Drugs
Press Release
Oct 8, 2019
| Rachel Schwartz
AAM Response to CA Governor Newsom Signing AB 824
Blog
Oct 7, 2019
| Erica Klinger
A Positive Impact: How Our Members Show They Care
Blog
Oct 3, 2019
| Jennifer Soup
GRx+Biosims Spotlight: The Exposition
Video
Oct 1, 2019
| Erica Klinger
35 Year Anniversary of Generic Medicines
Video
Sep 30, 2019
| Erica Klinger
Generic Medicines 35th Birthday Celebration
Blog
Sep 26, 2019
| Craig Burton
Three Recommendations to Save Money for Seniors and Taxpayers by Updating Medicare Part D
Blog
Sep 23, 2019
| Erica Klinger
Happy Birthday, Generic Prescription Drugs: 35 Years of Competition
Report
Sep 20, 2019
| Craig Burton
White Paper: Access Denied: Why New Generics Are Not Reaching America's Seniors
Press Release
Sep 20, 2019
| Rachel Schwartz
Seniors Denied Access to New, Lower-Priced Generic Drugs Due to Medicare Coverage Delays
Report
Sep 18, 2019
| Erica Klinger
Report: 2019 Generic Drug & Biosimilars Access & Savings in the U.S.
Report
Sep 9, 2019
| Craig Burton
White Paper Part 2: Failure to Launch: Barriers to Biosimilar Market Adoption
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action